Genome Analyzer by Illumina, Inc., AB SOLiD by Life Technologies Corporation, and Roche 454 and HeliScope by Helicos Biotechnologies are the technologically updated system available in the market currently. introduced the GeneChip microarray in 1993 and to date, the company is engaged in continuous product modification to achieve higher efficiencies.
The industry is majorly driven by the continuous technological up-gradation, rising demand for more compact and reliable products, and the introduction of robust and efficient methodologies. Primary aim behind transcriptome analysis is to identify differentially expressed genes and to gain proper understanding on disease condition.Īccording to the International Review of Cell and Molecular Biology transcriptomic is aimed to establish the genetic cause of disease conditions by analyzing DNA or RNA profiles through advanced computational models. These transcriptomics datasets are products by various high-throughput methods such as next-generation sequencing and microarray analysis as it usually demands quantitative measurement of thousands of genes. Transcriptomics is defined as the study of RNA transcripts that are produced by the genome under specific conditions in specified cell bodies. The Transcriptomics Technologies market is estimated to represent a global market of USD 2.69 billion by 2019 with growth rate of 5.5%.
0 kommentar(er)
